Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HP INCHPQ · Entity 642 | Director · Interim CEO | February 03, 2026 | February 05, 2026 |
| KEYCORP /NEW/KEY · Entity 3220 | Director | July 01, 2021 | July 06, 2021 |
| MARSH & MCLENNAN COMPANIES, INC.MRSH · Entity 1501 | Director | August 15, 2026 | August 18, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HP INC
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 344,149 |
Reported balance
After 2026-02-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 344,149 · Balance 344,149 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.
KEYCORP /NEW/
Report date July 01, 2021 · Filed July 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 19,587 |
Reported balance
After 2021-07-01 transaction · row 1
1 source rowRow 1 · 2021-07-01 · Exercise / conversion · Acquired 6,781 · Balance 19,587 F1: Each Deferred Share is the economic equivalent of one Common Share. |
| Deferred SharesSEC Table II · derivative / convertible security · Expires 2021-07-01 | Direct | 27,263 |
Reported balance
After 2021-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-01 · Exercise / conversion · Disposed 6,781 · Balance 27,263 F1: Each Deferred Share is the economic equivalent of one Common Share. F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 11,778 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,778 F2: These shares are held in a living trust. The reporting person is trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share is the economic equivalent of one Common Share.
F2: These shares are held in a living trust. The reporting person is trustee of the trust.
F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021.
MARSH & MCLENNAN COMPANIES, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,617 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 192 · Balance 1,617 F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 4,595 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 4,595 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,319 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,319 · Balance 1,319 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date July 01, 2024 · Filed July 01, 2024
Section 16 reporting ended · disclosed 2024-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 85,130 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 85,130 F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 25,000 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 25,000 F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 13,430 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 13,430 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 30,425 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 30,425 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 23,734 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,734 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 26,484 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 26,484 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,184 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,184 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,573 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 4,573 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,012 F13 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's daughter, effective August 25, 2020. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| May 21, 2020 Filed May 26, 2020 22:28 UTC | KEYCORP /NEW/ KEY · Entity 3220 | GrantDeferred Shares · Derivative | 12,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001799551-20-000048 · edgar.xml · derivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,759 Underlying: Common Shares · 12,138 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F4 · price: The Deferred Shares were awarded under the Deferred Share Plan. F3 · derivative.exercise_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 21, 2023. F3 · derivative.expiration_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 21, 2023. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:58 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionDeferred Shares · Derivative | 7,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001799551-20-000043 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,621 Underlying: Common Shares · 7,497 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 18, 2020, 3,748 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,749 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 18, 2020, 3,748 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,749 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F4 · balance_after: Includes approximately 943 dividend-equivalent Deferred Shares accrued between June 2019 and March 2020. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:58 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Disposition to issuerCommon Shares | 3,748 | $10.71 | $40,141.08 |
DisclosureSEC source: 0001799551-20-000043 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,556 Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:58 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionCommon Shares | 7,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001799551-20-000043 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 18, 2020, 3,748 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,749 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F2 · balance_after: Includes approximately 307 common shares acquired through dividend reinvestment. Read SEC document |
| May 01, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,172 F12 · shares: Shares represent a charitable gift/donation, effective May 1, 2020, in which no value was received in return. Read SEC document |
| May 01, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 6,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,018 F11 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's son, effective May 1, 2020. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| May 01, 2020 Filed Nov 6, 2020 18:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 6,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000147 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,768 F10 · shares: Shares transferred represent a gift to a Trust in the name of affiliate's daughter, effective May 1, 2020. Affiliate is not a Trustee and has no pecuniary interest or investment discretion. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:36 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 8,018 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000042 · edgar.xml · derivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,018 Underlying: Humana Common · 8,018 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:36 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 40,290 | $0.00 Strike: $350.79 | $0.00 |
DisclosureSEC source: 0000049071-20-000042 · edgar.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,290 Underlying: Humana Common · 40,290 shares Expires 2027-02-24 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · derivative · entry 15 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,089 Underlying: Humana Common · 3,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.exercise_price: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · derivative · entry 14 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415 Underlying: Humana Common · 3,414 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · derivative · entry 13 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 8,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,371 | $350.41 | $480,412.11 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,297 Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,537 | $350.41 | $538,580.17 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,624 Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 3,658 | $350.41 | $1,281,799.78 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,747 Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 8,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 70,352 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,636 Underlying: Humana Common · 70,352 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 11,778 | $346.17 | $4,077,131.37 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,279 F9 · price: Shares swapped for payment of taxes on stock option exercise using fair market value on December 12, 2019 pursuant to Humana Inc's 2011 Stock Incentive Plan Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 44,371 | $344.73 | $15,295,792.98 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,057 F8 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on December 11, 2019 pursuant to Humana Inc's 2011 Stock Incentive Plan Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 19:08 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 70,352 | $217.42 | $15,295,580.08 |
DisclosureSEC source: 0000049071-19-000128 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:46 UTC | KEYCORP /NEW/ KEY · Entity 3220 | GrantDeferred Shares · Derivative | 7,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001294671-19-000038 · edgar.xml · derivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,176 Underlying: Common Shares · 7,869 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 23, 2022. F2 · derivative.expiration_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 23, 2022. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:20 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionDeferred Shares · Derivative | 9,610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001294671-19-000032 · edgar.xml · derivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,307 Underlying: Common Shares · 9,610 shares Expires 2019-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 17, 2019, 4,805 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 4,805 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 17, 2019, 4,805 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 4,805 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F2 · balance_after: Includes approximately 794 dividend-equivalent Deferred Shares accrued between June 2018 and March 2019. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:20 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Disposition to issuerCommon Shares | 4,805 | $16.75 | $80,483.75 |
DisclosureSEC source: 0001294671-19-000032 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,529 Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:20 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionCommon Shares | 9,610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001294671-19-000032 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 17, 2019, 4,805 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 4,805 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| February 25, 2019 Filed Mar 1, 2019 23:36 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000045 · edgar.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,133 Underlying: Humana Common · 9,133 shares Expires not disclosed F7 · security: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.exercise_price: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/25/2019, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. Read SEC document |
| February 25, 2019 Filed Mar 1, 2019 23:36 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 40,409 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0000049071-19-000045 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,409 Underlying: Humana Common · 40,409 shares Expires 2026-02-25 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 39,147 | $0.00 Strike: $167.81 | $0.00 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 39,147 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three annual increments. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 24,384 | $310.65 | $7,574,877.41 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,076 F9 · price: Shares sold at prices ranging from $309.615 to $311.195. Price reported is weighted average sales price. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 324 | $308.52 | $99,960.48 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,460 F7 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on February 21, 2019 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 595 | $167.81 | $99,843.98 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 7,515 | $308.79 | $2,320,556.85 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,189 F8 · price: Shares swapped for payment of taxes on stock option exercise using fair market value on February 22, 2019 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 20,969 | $308.52 | $6,469,355.88 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,704 F7 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on February 21, 2019 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 22:14 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 38,552 | $167.81 | $6,469,218.36 |
DisclosureSEC source: 0000049071-19-000028 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Underlying: Humana Common · 3,414 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,126 Underlying: Humana Common · 8,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,693 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 8,693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,552 | $304.05 | $471,877.84 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,121 Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 3,694 | $304.05 | $1,123,142.23 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,259 Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 8,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 3,951 | $304.05 | $1,201,281.80 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,827 Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 15:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 8,693 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000140 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 13:53 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 18,000 | $328.66 | $5,915,878.20 |
DisclosureSEC source: 0000049071-18-000117 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,085 F8 · price: Shares sold at prices ranging from $328.10 to $329.03. Price reported is weighted average sales price. Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:13 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionDeferred Shares · Derivative | 6,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001294671-18-000053 · edgar.xml · derivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,123 Underlying: Common Shares · 6,448 shares Expires 2018-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 21, 2018, 3,224 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,224 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 21, 2018, 3,224 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,224 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:13 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Disposition to issuerCommon Shares | 3,224 | $20.25 | $65,286.00 |
DisclosureSEC source: 0001294671-18-000053 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,724 Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:13 UTC | KEYCORP /NEW/ KEY · Entity 3220 | Exercise / conversionCommon Shares | 6,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001294671-18-000053 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 21, 2018, 3,224 of the Reporting Person's Deferred Shares were settled for cash, and the remaining 3,224 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:05 UTC | KEYCORP /NEW/ KEY · Entity 3220 | GrantDeferred Shares · Derivative | 5,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001294671-18-000037 · edgar.xml · derivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 Underlying: Common Shares · 5,917 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2013 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2021. F2 · derivative.expiration_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2013 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2021. F4 · balance_after: Includes approximately 463 dividend-equivalent Deferred Shares accrued between June 2017 and March 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.